21
Feb
22
Feb

Dublin

Presented by

IPHA IPHA
BPCI BPCI
NIBRT NIBRT

Event Sponsors

PWC PWC
McKesson McKesson

Agency partners

Intertrade Ireland Intertrade Ireland
IDA Ireland IDA Ireland

Day 2 Plenary session

08:00
Delegate registration with light refreshments
08:30
David Keyes, Director of United Drug Distributors Ireland Limited and Head of Public Affairs and Country Board Member McKesson Ireland
Welcome address
08:35
Minister for Health, Simon Harris, TD
Opening address
Session 3: Unlocking the collaborative potential of data and clinical research
Chaired by Eibhlín Mulroe, Chief Executive Officer, Cancer Trials Ireland
9:00


9:30


10:00
- Dr Richard L. Schilsky, MD, FACP, FSCT, FASCO, Senior Vice President and Chief Medical Officer, American Society of Clinical Oncology (ASCO)
Improving the efficiency of clinical trials and the effectiveness of clinical care through data sharing

- Dr Muhammed Ali, Executive Director, Regional Healthcare Solutions Strategy, MSD International
Augmented learning in industry, the gift of artificial intelligence

Panel discussion with Dr Pat O’ Mahony, Chief Executive, Clinical Research Development Ireland (CRDI) and Prof Bryan Hennessy, Clinical Lead, Cancer Trials Ireland
10:25
Networking break
Session 4: Manufacturing for the future
Chair: David Keenan, Chairman, BioPharmaChem Ireland and Vice President Global External Supply and Managing Director Mallinckrodt Pharmaceuticals Ireland
11:00


11:20


11:40


12:00


12:20


12:40
- Dominic Carolan, Chief Executive Officer, National Institute for Bioprocessing Research and Training (NIBRT)
Trends in Biopharma Manufacturing

- Dr Michael Zaworotko, Bernal Chair of Crystal Engineering & Science Foundation of Ireland Research Professor, University of Limerick, Ireland
Why crystals matter to the real world

- Brendan O’Callaghan, Senior Vice President and Global Head Biologics Platform, Sanofi
Bio-Manufacturing of the future – meeting the needs of an evolving pipeline

- Graham Symcox, Managing Director, PharmaCentaur AG
Integrated CMC – key to the time to market and time to peak sales

-Jean Delaney, Pharmaceutical & Life Sciences Leader and Tax Partner, PwC Ireland
The changing tax environment for manufacturing investment

Panel discussion
12:55
Networking lunch
Session 5: Adopting innovation; Delivering value
13:35


13:55


14:15


14:35
- Moheb Nasr, Ph.D.
Manufacturing innovation: Regulatory considerations

- Dr Lynn Allen-Hoffmann, Senior Vice President Regenerative Medicine, Stratatech – A Mallinckrodt Company
StrataGraft: Discovery to Phase III clinical trial

- Nathalie Moll, Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA).
IP Incentives – key to unlocking innovation

Panel discussion
14:55
Closing address
Matt Moran, Director, BioPharmaChem Ireland
Close